Takeda Pharmaceutical Company Limited Other Comprehensive Income Net Of Tax Cash Flow Hedges
Takeda Pharmaceutical Company Limited (TKPHF) reported Other Comprehensive Income Net Of Tax Cash Flow Hedges of -JPY 956.00 million for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:OtherComprehensiveIncomeNetOfTaxCashFlowHedges · last filed 2025-06-25
| Period end | Other Comprehensive Income Net Of Tax Cash Flow Hedges 12 month |
|---|---|
| 2025-03-31 | -956.00M JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 23.46B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | -21.45B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 2.17B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | -45.34B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | -25.69B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | -33.79B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 1.92B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 4.63B JPY 20-F · filed 2019-06-27 |